期刊
NEPHROLOGY DIALYSIS TRANSPLANTATION
卷 28, 期 6, 页码 1434-1439出版社
OXFORD UNIV PRESS
DOI: 10.1093/ndt/gfs554
关键词
blood pressure; ejection fraction; glomerular filtration rate; SDMA
资金
- Else-Kroner-Fresenius Foundation [P63/06/EKMS 06/03]
Symmetrical dimethylarginine (SDMA), the structural isomer of the nitric oxide synthase inhibitor asymmetrical dimethylarginine, has long been regarded as an inert substance. Recent epidemiological and preclinical data suggest that it might be involved in the pathophysiology of renal and cardiovascular diseases. Therefore, we aimed to investigate the effect of chronic SDMA infusion on renal and cardiac function in mice. Eight-week-old male C57Bl/6 mice received vehicle-controlled infusion of SDMA (250 mol/kg/days) for 28 days using osmotic minipumps (n 24/group). The following parameters were monitored: glomerular filtration rate (GFR; fluoresceinyl thiocarbamoyl-inulin excretion kinetic), cardiac function (echocardiography) and blood pressure (tail cuff). Blood samples for SDMA determination were obtained at baseline, 2 and 4 weeks. Mice were euthanized at 4 weeks to obtain tissue for renal histology. Chronic SDMA infusion led to a significant increase of SDMA levels from 0.26 0.10 to 3.49 1.66 mol/L (P 0.001) at 4 weeks. Despite this SDMA increase, the GFR did not change (1224 351 versus 1017 345 mL/min/g body weight, n.s.) at 4 weeks, when compared with baseline. We did not find any histological changes, particularly no effect on fibrosis or endothelias nitric oxide synthase expression. There was neither an effect of SDMA on systolic blood pressure (106 12 versus 111 18 mmHg, n.s.) nor on ejection fraction (54.2 1.7 versus 58.4 1.9, n.s.). Based on our experiments, it seems unlikely that chronically elevated SDMA alone has an effect on renal and cardiac function in otherwise healthy mice. Future studies have to clarify the potential pathophysiological role of SDMA in cardiovascular disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据